Skip to main content
PMC home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):60–67. doi: 10.1136/hrt.76.3_suppl_3.60

The renin-angiotensin-aldosterone system and cardiac ischaemia

H Ikram 1
PMCID: PMC484490  PMID: 8983666

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberg G., Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990;15 (Suppl 5):S65–S72. [PubMed] [Google Scholar]
  2. Ahmed S. S., Levinson G. E., Weisse A. B., Regan T. J. The effect of angiotensin on myocardial contractility. J Clin Pharmacol. 1975 Apr;15(4 Pt 1):276–285. doi: 10.1002/j.1552-4604.1975.tb01449.x. [DOI] [PubMed] [Google Scholar]
  3. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med. 1995 Jan 12;332(2):80–85. doi: 10.1056/NEJM199501123320203. [DOI] [PubMed] [Google Scholar]
  4. Chobanian A. V., Haudenschild C. C., Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990 Mar;15(3):327–331. doi: 10.1161/01.hyp.15.3.327. [DOI] [PubMed] [Google Scholar]
  5. Cleland J. G., Henderson E., McLenachan J., Findlay I. N., Dargie H. J. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol. 1991 Mar 1;17(3):733–739. doi: 10.1016/s0735-1097(10)80192-5. [DOI] [PubMed] [Google Scholar]
  6. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  7. Daly P., Mettauer B., Rouleau J. L., Cousineau D., Burgess J. H. Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect. Circulation. 1985 Feb;71(2):317–325. doi: 10.1161/01.cir.71.2.317. [DOI] [PubMed] [Google Scholar]
  8. De Mello W. C. The cardiac renin-angiotensin system: its possible role in cell communication and impulse propagation. Cardiovasc Res. 1995 Jun;29(6):730–736. doi: 10.1016/0008-6363(96)88606-8. [DOI] [PubMed] [Google Scholar]
  9. Diz D. I., Barnes K. L., Ferrario C. M. Contribution of the vagus nerve to angiotensin II binding sites in the canine medulla. Brain Res Bull. 1986 Oct;17(4):497–505. doi: 10.1016/0361-9230(86)90217-0. [DOI] [PubMed] [Google Scholar]
  10. Dohi Y., Hahn A. W., Boulanger C. M., Bühler F. R., Lüscher T. F. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992 Feb;19(2):131–137. doi: 10.1161/01.hyp.19.2.131. [DOI] [PubMed] [Google Scholar]
  11. Drexler H., Depenbusch J. W., Truog A. G., Zelis R., Flaim S. F. Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure. J Pharmacol Exp Ther. 1987 Apr;241(1):13–19. [PubMed] [Google Scholar]
  12. Emori T., Hirata Y., Ohta K., Kanno K., Eguchi S., Imai T., Shichiri M., Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991 Aug;18(2):165–170. doi: 10.1161/01.hyp.18.2.165. [DOI] [PubMed] [Google Scholar]
  13. Ertl G., Alexander R. W., Kloner R. A. Interactions between coronary occlusion and the renin-angiotensin system in the dog. Basic Res Cardiol. 1983 Sep-Oct;78(5):518–533. doi: 10.1007/BF01906463. [DOI] [PubMed] [Google Scholar]
  14. Ertl G. Coronary vasoconstriction in experimental myocardial ischemia. J Cardiovasc Pharmacol. 1987;9 (Suppl 2):S9–17. doi: 10.1097/00005344-198700002-00004. [DOI] [PubMed] [Google Scholar]
  15. Farber H. W., Center D. M., Rounds S., Danilov S. M. Components of the angiotensin system cause release of a neutrophil chemoattractant from cultured bovine and human endothelial cells. Eur Heart J. 1990 Apr;11 (Suppl B):100–107. doi: 10.1093/eurheartj/11.suppl_b.100. [DOI] [PubMed] [Google Scholar]
  16. Faxon D. P., Creager M. A., Halperin J. L., Bernard D. B., Ryan T. J. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure. Am J Med. 1984 May 31;76(5B):104–110. doi: 10.1016/0002-9343(84)90895-7. [DOI] [PubMed] [Google Scholar]
  17. Faxon D. P., Creager M. A., Halperin J. L., Sussman H. A., Gavras H., Ryan T. J. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease. Int J Cardiol. 1982;2(2):251–262. doi: 10.1016/0167-5273(82)90040-7. [DOI] [PubMed] [Google Scholar]
  18. Foult J. M., Tavolaro O., Antony I., Nitenberg A. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation. 1988 Feb;77(2):337–344. doi: 10.1161/01.cir.77.2.337. [DOI] [PubMed] [Google Scholar]
  19. Foy S. G., Crozier I. G., Richards A. M., Nicholls M. G., Turner J. G., Frampton C. M., Ikram H. Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition. Eur Heart J. 1995 Jun;16(6):770–778. doi: 10.1093/oxfordjournals.eurheartj.a060995. [DOI] [PubMed] [Google Scholar]
  20. Foy S. G., Crozier I. G., Turner J. G., Richards A. M., Frampton C. M., Nicholls M. G., Ikram H. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study). Am J Cardiol. 1994 Jun 15;73(16):1180–1186. doi: 10.1016/0002-9149(94)90178-3. [DOI] [PubMed] [Google Scholar]
  21. Gibbons G. H., Dzau V. J. The emerging concept of vascular remodeling. N Engl J Med. 1994 May 19;330(20):1431–1438. doi: 10.1056/NEJM199405193302008. [DOI] [PubMed] [Google Scholar]
  22. Ikram H., Low C. J., Shirlaw T., Webb C. M., Richards A. M., Crozier I. G. Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris. Am J Cardiol. 1990 Jul 15;66(2):164–167. doi: 10.1016/0002-9149(90)90581-k. [DOI] [PubMed] [Google Scholar]
  23. KOCH-WESER J. MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res. 1964 Apr;14:337–344. doi: 10.1161/01.res.14.4.337. [DOI] [PubMed] [Google Scholar]
  24. KOCH-WESER J. NATURE OF THE INOTROPIC ACTION OF ANGIOTENSIN ON VENTRICULAR MYOCARDIUM. Circ Res. 1965 Mar;16:230–237. doi: 10.1161/01.res.16.3.230. [DOI] [PubMed] [Google Scholar]
  25. Kannel W. B., Gordon T., Castelli W. P., Margolis J. R. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med. 1970 Jun;72(6):813–822. doi: 10.7326/0003-4819-72-6-813. [DOI] [PubMed] [Google Scholar]
  26. Kingma J. H., van Gilst W. H., Peels C. H., Dambrink J. H., Verheugt F. W., Wielenga R. P. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril and Thrombolysis Study (CATS). Eur Heart J. 1994 Jul;15(7):898–907. doi: 10.1093/oxfordjournals.eurheartj.a060608. [DOI] [PubMed] [Google Scholar]
  27. Kiowski W., Lüscher T. F., Linder L., Bühler F. R. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation. 1991 Feb;83(2):469–475. doi: 10.1161/01.cir.83.2.469. [DOI] [PubMed] [Google Scholar]
  28. Klein W. W., Khurmi N. S., Eber B., Dusleag J. Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina. J Am Coll Cardiol. 1990 Oct;16(4):948–956. doi: 10.1016/s0735-1097(10)80347-x. [DOI] [PubMed] [Google Scholar]
  29. Kramer H. J., Glänzer K., Meyer-Lehnert H., Mohaupt M., Predel H. G. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones. J Cardiovasc Pharmacol. 1990;15 (Suppl 6):S91–S98. [PubMed] [Google Scholar]
  30. Laskey W. K., Kussmaul W. G. Arterial wave reflection in heart failure. Circulation. 1987 Apr;75(4):711–722. doi: 10.1161/01.cir.75.4.711. [DOI] [PubMed] [Google Scholar]
  31. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–1566. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
  32. Liang C. S., Gavras H., Hood W. B., Jr Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics. J Clin Invest. 1978 Apr;61(4):874–883. doi: 10.1172/JCI109013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lindpaintner K., Jin M., Wilhelm M. J., Suzuki F., Linz W., Schoelkens B. A., Ganten D. Intracardiac generation of angiotensin and its physiologic role. Circulation. 1988 Jun;77(6 Pt 2):I18–I23. [PubMed] [Google Scholar]
  34. Lüscher T. F., Boulanger C. M., Dohi Y., Yang Z. H. Endothelium-derived contracting factors. Hypertension. 1992 Feb;19(2):117–130. doi: 10.1161/01.hyp.19.2.117. [DOI] [PubMed] [Google Scholar]
  35. Magrini F., Reggiani P., Fratianni G., Morganti A., Zanchetti A. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension. J Cardiovasc Pharmacol. 1992;19 (Suppl 5):S128–S133. [PubMed] [Google Scholar]
  36. Martorana P. A., Kettenbach B., Breipohl G., Linz W., Schölkens B. A. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol. 1990 Jul 3;182(2):395–396. doi: 10.1016/0014-2999(90)90301-l. [DOI] [PubMed] [Google Scholar]
  37. McAlpine H. M., Morton J. J., Leckie B., Rumley A., Gillen G., Dargie H. J. Neuroendocrine activation after acute myocardial infarction. Br Heart J. 1988 Aug;60(2):117–124. doi: 10.1136/hrt.60.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. McLenachan J. M., Henderson E., Morris K. I., Dargie H. J. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987 Sep 24;317(13):787–792. doi: 10.1056/NEJM198709243171302. [DOI] [PubMed] [Google Scholar]
  39. Messerli F. H., Ketelhut R. Left ventricular hypertrophy: an independent risk factor. J Cardiovasc Pharmacol. 1991;17 (Suppl 4):S59–S67. [PubMed] [Google Scholar]
  40. Mettauer B., Rouleau J. L., Daly P. The effect of captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease. Postgrad Med J. 1986;62 (Suppl 1):54–58. [PubMed] [Google Scholar]
  41. Michel J. B., Plissonnier D., Bruneval P. Effect of perindopril on the immune arterial wall remodeling in the rat model of arterial graft rejection. Am J Med. 1992 Apr 27;92(4B):39S–46S. doi: 10.1016/0002-9343(92)90146-3. [DOI] [PubMed] [Google Scholar]
  42. Motz W., Vogt M., Scheler S., Schwartzkopff B., Strauer B. E. Coronary circulation in arterial hypertension. J Cardiovasc Pharmacol. 1991;17 (Suppl 2):S35–S39. doi: 10.1097/00005344-199117002-00009. [DOI] [PubMed] [Google Scholar]
  43. Muller J. E., Stone P. H., Turi Z. G., Rutherford J. D., Czeisler C. A., Parker C., Poole W. K., Passamani E., Roberts R., Robertson T. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985 Nov 21;313(21):1315–1322. doi: 10.1056/NEJM198511213132103. [DOI] [PubMed] [Google Scholar]
  44. NISHITH S. D., DAVIS L. D., YOUMANS W. B. Cardioaccelerator action of angiotensin. Am J Physiol. 1962 Feb;202:237–240. doi: 10.1152/ajplegacy.1962.202.2.237. [DOI] [PubMed] [Google Scholar]
  45. Naftilan A. J., Gilliland G. K., Eldridge C. S., Kraft A. S. Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol. 1990 Oct;10(10):5536–5540. doi: 10.1128/mcb.10.10.5536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Naftilan A. J., Pratt R. E., Dzau V. J. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989 Apr;83(4):1419–1424. doi: 10.1172/JCI114032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Noguchi K., Kato T., Ito H., Aniya Y., Sakanashi M. Effect of intracoronary captopril on coronary blood flow and regional myocardial function in dogs. Eur J Pharmacol. 1985 Mar 26;110(1):11–19. doi: 10.1016/0014-2999(85)90023-8. [DOI] [PubMed] [Google Scholar]
  48. Pearson J. M. HEMIPLEGIA IN TYPHOID FEVER. Can Med Assoc J. 1912 Dec;2(12):1120–1121. [PMC free article] [PubMed] [Google Scholar]
  49. Perondi R., Saino A., Tio R. A., Pomidossi G., Gregorini L., Alessio P., Morganti A., Zanchetti A., Mancia G. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 1992 Jun;85(6):2004–2013. doi: 10.1161/01.cir.85.6.2004. [DOI] [PubMed] [Google Scholar]
  50. Phillips M. I. Functions of angiotensin in the central nervous system. Annu Rev Physiol. 1987;49:413–435. doi: 10.1146/annurev.ph.49.030187.002213. [DOI] [PubMed] [Google Scholar]
  51. Powell J. S., Clozel J. P., Müller R. K., Kuhn H., Hefti F., Hosang M., Baumgartner H. R. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989 Jul 14;245(4914):186–188. doi: 10.1126/science.2526370. [DOI] [PubMed] [Google Scholar]
  52. Powell J. S., Müller R. K., Rouge M., Kuhn H., Hefti F., Baumgartner H. R. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol. 1990;16 (Suppl 4):S42–S49. doi: 10.1097/00005344-199016004-00010. [DOI] [PubMed] [Google Scholar]
  53. Rademaker M. T., Fitzpatrick M. A., Charles C. J., Frampton C. M., Richards A. M., Nicholls M. G., Espiner E. A. Central angiotensin II AT1-receptor antagonism in normal and heart-failed sheep. Am J Physiol. 1995 Aug;269(2 Pt 2):H425–H432. doi: 10.1152/ajpheart.1995.269.2.H425. [DOI] [PubMed] [Google Scholar]
  54. Remme W. J., de Leeuw P. W., Bootsma M., Look M. P., Kruijssen D. A. Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris. Am J Cardiol. 1991 Jul 15;68(2):181–186. doi: 10.1016/0002-9149(91)90741-3. [DOI] [PubMed] [Google Scholar]
  55. Ridker P. M., Gaboury C. L., Conlin P. R., Seely E. W., Williams G. H., Vaughan D. E. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation. 1993 Jun;87(6):1969–1973. doi: 10.1161/01.cir.87.6.1969. [DOI] [PubMed] [Google Scholar]
  56. Rutherford J. D., Pfeffer M. A., Moyé L. A., Davis B. R., Flaker G. C., Kowey P. R., Lamas G. A., Miller H. S., Packer M., Rouleau J. L. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation. 1994 Oct;90(4):1731–1738. doi: 10.1161/01.cir.90.4.1731. [DOI] [PubMed] [Google Scholar]
  57. Saito K., Gutkind J. S., Saavedra J. M. Angiotensin II binding sites in the conduction system of rat hearts. Am J Physiol. 1987 Dec;253(6 Pt 2):H1618–H1622. doi: 10.1152/ajpheart.1987.253.6.H1618. [DOI] [PubMed] [Google Scholar]
  58. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  59. Scott-Burden T., Resink T. J., Hahn A. W., Bühler F. R. Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II. J Cardiovasc Pharmacol. 1990;16 (Suppl 7):S17–S20. [PubMed] [Google Scholar]
  60. Shell W. E., Dobson D. Dissociation of exercise tolerance and total myocardial ischemic burden in chronic stable angina pectoris. Am J Cardiol. 1990 Jul 1;66(1):42–48. doi: 10.1016/0002-9149(90)90733-h. [DOI] [PubMed] [Google Scholar]
  61. Sigurdsson A., Held P., Swedberg K. Short- and long-term neurohormonal activation following acute myocardial infarction. Am Heart J. 1993 Nov;126(5):1068–1076. doi: 10.1016/0002-8703(93)90656-t. [DOI] [PubMed] [Google Scholar]
  62. Simon J., Gibbs R., Crean P. A., Mockus L., Wright C., Sutton G. C., Fox K. M. The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina. Br Heart J. 1989 Aug;62(2):112–117. doi: 10.1136/hrt.62.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Strozzi C., Cocco G., Portaluppi F., Urso L., Alfiero R., Tasini M. T., Montanari L., Al Yassini K., Rizzo A. Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris. Cardiology. 1987;74(3):226–228. doi: 10.1159/000174201. [DOI] [PubMed] [Google Scholar]
  64. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  65. Søgaard P., Gøtzsche C. O., Ravkilde J., Thygesen K. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation. 1993 Apr;87(4):1093–1099. doi: 10.1161/01.cir.87.4.1093. [DOI] [PubMed] [Google Scholar]
  66. Taddei S., Virdis A., Mattei P., Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993 Jun;21(6 Pt 2):929–933. doi: 10.1161/01.hyp.21.6.929. [DOI] [PubMed] [Google Scholar]
  67. Taubman M. B., Berk B. C., Izumo S., Tsuda T., Alexander R. W., Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem. 1989 Jan 5;264(1):526–530. [PubMed] [Google Scholar]
  68. Turlapaty P. D., Altura B. M. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science. 1980 Apr 11;208(4440):198–200. doi: 10.1126/science.7361117. [DOI] [PubMed] [Google Scholar]
  69. Urata H., Kinoshita A., Misono K. S., Bumpus F. M., Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990 Dec 25;265(36):22348–22357. [PubMed] [Google Scholar]
  70. Webster M. W., Fitzpatrick M. A., Nicholls M. G., Ikram H., Wells J. E. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 1985 Sep 15;56(8):566–569. doi: 10.1016/0002-9149(85)91186-5. [DOI] [PubMed] [Google Scholar]
  71. Wiemer G., Schölkens B. A., Becker R. H., Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991 Oct;18(4):558–563. doi: 10.1161/01.hyp.18.4.558. [DOI] [PubMed] [Google Scholar]
  72. Xiang J. Z., Linz W., Becker H., Ganten D., Lang R. E., Schölkens B., Unger T. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol. 1985 Jul 17;113(2):215–223. doi: 10.1016/0014-2999(85)90738-1. [DOI] [PubMed] [Google Scholar]
  73. Yamazaki M., Toda N. Comparison of responses to angiotensin II of dog mesenteric arteries and veins. Eur J Pharmacol. 1991 Aug 29;201(2-3):223–229. doi: 10.1016/0014-2999(91)90349-u. [DOI] [PubMed] [Google Scholar]
  74. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]
  75. van Gilst W. H., Scholtens E., de Graeff P. A., de Langen C. D., Wesseling H. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation. Circulation. 1988 Jun;77(6 Pt 2):I24–I29. [PubMed] [Google Scholar]
  76. van Gilst W. H., de Graeff P. A., Wesseling H., de Langen C. D. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):722–728. [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES